Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration
about
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic.The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort studyTherapeutic drug monitoring of antimicrobials.Presence and accuracy of drug dosage recommendations for continuous renal replacement therapy in tertiary drug information references.Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial.Maximally effective dosing regimens of meropenem in patients with septic shock.Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study.Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients.Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and VaborbactamAltered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?
P2860
Q33821554-59537E80-5208-40D7-98C6-63751DFB0284Q34329290-B842E4C1-871B-485F-80FC-7AB7FBD55722Q34996307-4FD64FEC-F27F-42C8-AFBB-A63973DFFDB1Q35640430-5989DB2F-B45D-41F0-8ECE-6B2252CA2B72Q36048276-2C0A278C-42BF-4E8F-8B10-99E5E6D486DEQ36287127-FEBEE219-829D-4A39-837D-7B707827C4D2Q38004063-7F036F49-3F75-46E5-B5E9-948996A3670AQ39048274-9BD6FAFF-612F-4907-B7B6-064B09441A7AQ39344408-D1AE4191-9CF4-4018-AC39-B8D1C0A61EDEQ39965478-1F54D8F2-FD44-4706-AB23-66B65B0CF88DQ41692446-62ED0DA4-F48E-4A6E-B9ED-3D6B507F0BA1Q42232248-23745038-5782-4208-8F89-3DE9B45E6BC4Q46457513-76B32D00-FA13-4FB5-9721-4BF20933C24DQ47624900-6C8CB51A-4E27-4CE4-9DE2-5309CCE3BE7AQ48139759-AAEE3912-A517-449E-B357-C521DBE61C48Q49894608-F2DAA605-0D7B-428F-A7B5-114FA9733FD1Q58701126-58146F11-BE2B-473D-B1C6-FFBAEA20D4E5Q58812745-4BC6934B-3216-4040-B5CD-139EB73E97A0
P2860
Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Meropenem dosing in critically ...... uous venovenous hemofiltration
@ast
Meropenem dosing in critically ...... uous venovenous hemofiltration
@en
Meropenem dosing in critically ...... uous venovenous hemofiltration
@nl
type
label
Meropenem dosing in critically ...... uous venovenous hemofiltration
@ast
Meropenem dosing in critically ...... uous venovenous hemofiltration
@en
Meropenem dosing in critically ...... uous venovenous hemofiltration
@nl
prefLabel
Meropenem dosing in critically ...... uous venovenous hemofiltration
@ast
Meropenem dosing in critically ...... uous venovenous hemofiltration
@en
Meropenem dosing in critically ...... uous venovenous hemofiltration
@nl
P2093
P2860
P50
P356
P1476
Meropenem dosing in critically ...... uous venovenous hemofiltration
@en
P2093
P2860
P304
P356
10.1128/AAC.01582-09
P407
P577
2010-05-17T00:00:00Z